| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/14/2011 | CN101766571B Cefpiramide, sodium benzoate, sodium bicarbonate pharmaceutical composite lipidosome injection |
| 09/14/2011 | CN101756898B Lansoprazole sodium suspension preparation for injection and new application thereof |
| 09/14/2011 | CN101735410B Reduction-sensitive amphiphilic block copolymer and micelle thereof |
| 09/14/2011 | CN101721391B Method for preventing cell-carrying sodium alginate microcapsule from shrinking |
| 09/14/2011 | CN101711736B Method for preparing medicine-carrying microvesicle |
| 09/14/2011 | CN101708336B Novel medicinal premixing auxiliary material |
| 09/14/2011 | CN101664384B N-acetyl-cysteine salt xylitol injection, preparation method and application thereof |
| 09/14/2011 | CN101647871B Peony pollen oral liquid and preparation method thereof |
| 09/14/2011 | CN101612437B In-situ implantation drug delivery system of naltrexone microsphere-hydrogel matrix |
| 09/14/2011 | CN101612131B 2-methoxyestradiol nanosuspension frozen powder and preparation method thereof |
| 09/14/2011 | CN101549060B Medicament containing gnetales for treating bronchitis and preparation method thereof |
| 09/14/2011 | CN101513523B Medicine containing cell polypeptide growth factor and preparation method thereof |
| 09/14/2011 | CN101508993B Bullfrog lectin gene, encoded lectin and uses thereof |
| 09/14/2011 | CN101496833B Liquid external preparation for preparing total alkaloids in nux vomica |
| 09/14/2011 | CN101455844B PEG-erythrocyte-stimulating factor and preparation method and use thereof |
| 09/14/2011 | CN101428142B Process for producing recombinant human vascular endothelial inhibitor composition sustained-release microsphere |
| 09/14/2011 | CN101336931B Iron liposomes used as iron supplementary |
| 09/14/2011 | CN101322720B Arsenic trioxide emulsion for intravenous injection and preparation thereof |
| 09/14/2011 | CN101314043B Preparation method of podophyllinic acid lactone derivant |
| 09/14/2011 | CN101292991B Compound gelling agent containing clindamycinum |
| 09/14/2011 | CN101016312B Method of preparing powder phosphatide and lecithin for medicine and injection from soybean oil residue |
| 09/13/2011 | US8017804 Lipids, lipid complexes and use thereof |
| 09/13/2011 | US8017742 Gene carrier |
| 09/13/2011 | US8017739 Conjugates of hydroxyalkyl starch and a protein |
| 09/13/2011 | US8017736 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
| 09/13/2011 | US8017733 Covalent attachment of hydrophilic polymers, such as polyalkylene glycol polymers, also known as polyalkylene oxides, to biologically-active molecules |
| 09/13/2011 | US8017727 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 09/13/2011 | US8017645 Melatonin daily dosage units |
| 09/13/2011 | US8017627 Fentanyl composition for nasal administration |
| 09/13/2011 | US8017595 Delivering therapeutic formulation containing N-sulphated-N,O-carboxymethylchitosan as a primary carrier across a membrane that has limited permeability for therapeutic agent |
| 09/13/2011 | US8017591 Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals |
| 09/13/2011 | US8017586 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 09/13/2011 | US8017581 MSH-agonist tripeptide conjugates |
| 09/13/2011 | US8017160 Concurrent administering magnesium salt and quaternary ammonium compound, phosphatides and, or acid |
| 09/13/2011 | US8017156 Long-acting colloidal insulin formulation and its preparation |
| 09/13/2011 | US8017151 Amphiphilic polymer-protein conjugates and methods of use thereof |
| 09/13/2011 | US8017144 Controlled release polymeric compositions of bone growth promoting compounds |
| 09/13/2011 | US8017143 Coating agent for drug releasing stent, preparation method thereof and drug releasing stent coated therewith |
| 09/13/2011 | US8017142 Polysulfone block copolymers as drug-eluting coating material |
| 09/13/2011 | US8017134 Recombinant toxin fragments |
| 09/13/2011 | US8017131 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 09/13/2011 | CA2640451C Medicine for transnasal administration |
| 09/13/2011 | CA2639407C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 09/13/2011 | CA2628857C Formulation and method for treating neoplasms by inhalation |
| 09/13/2011 | CA2518964C Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 09/13/2011 | CA2467763C Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 09/13/2011 | CA2453779C Cationic alkyd polyesters for medical applications |
| 09/13/2011 | CA2428800C In vivo use of fluid absorbent polymers |
| 09/13/2011 | CA2378187C Methods for treating therapy-resistant tumors |
| 09/13/2011 | CA2350519C Chromone enteric release formulation |
| 09/13/2011 | CA2297101C Receptor specific transepithelial transport of therapeutics |
| 09/12/2011 | CA2733694A1 Selegiline-containing adhesive preparation |
| 09/12/2011 | CA2733692A1 Selegiline-containing adhesive preparation |
| 09/12/2011 | CA2733633A1 Selegiline-containing adhesive preparation |
| 09/09/2011 | WO2011109787A1 Methods of administering insulinotropic peptides |
| 09/09/2011 | WO2011109784A1 Formulation of insulinotropic peptide conjugates |
| 09/09/2011 | WO2011109681A1 Fatty acid cox inhibitor derivatives and their uses |
| 09/09/2011 | WO2011109422A2 Compositions and methods for the treatment of cancer |
| 09/09/2011 | WO2011109415A2 Reducing viscosity of pharmaceutical formulations |
| 09/09/2011 | WO2011109294A1 Lipid delivery formulations |
| 09/09/2011 | WO2011108955A1 Multi -targeting system comprising a nanocarrier, nucleic acid(s) and non-nucleic acid based drug(s) |
| 09/09/2011 | WO2011108644A1 Solid pharmaceutical composition and pharmaceutical preparation |
| 09/09/2011 | WO2011108643A1 Film preparation containing medicament with unpleasant taste |
| 09/09/2011 | WO2011108624A1 Polymer of nitrogen-containing compound, method for producing same, and gene transfer agent |
| 09/09/2011 | WO2011108521A1 Mucosal vaccine |
| 09/09/2011 | WO2011107820A1 Surface immobilized chaperones |
| 09/09/2011 | WO2011107436A2 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| 09/09/2011 | WO2011107290A1 Magnetic nanoparticles for cancer diagnostic and treatment purposes |
| 09/09/2011 | WO2011106993A1 Gold nanoparticles modified by aminopyrimide, preparation method and use thereof |
| 09/09/2011 | WO2011106991A1 One kind of complex molecules of protein polypeptide and application thereof |
| 09/09/2011 | WO2011106877A1 Derivatized hyperbranched polyglycerols |
| 09/09/2011 | WO2011106858A1 Fast-dissolving solid pharmaceutical form for treating bacterial infections |
| 09/09/2011 | WO2011091307A8 Affinity hydrogels for controlled protein release |
| 09/09/2011 | WO2011086577A3 Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts |
| 09/09/2011 | WO2011086331A3 Method for manufacturing capsules having controlled head |
| 09/09/2011 | WO2011080102A3 Glp-1 analogues and derivatives |
| 09/09/2011 | WO2011076216A3 Wound care products |
| 09/09/2011 | WO2011067791A3 Process for preparing pharmaceutical ophthalmic compositions |
| 09/09/2011 | WO2011049958A3 Modulation of gel temperature of poloxamer-containing formulations |
| 09/09/2011 | WO2011049954A3 Compositions comprising wnt modulators or neurotoxins for the treatment of otic disorders |
| 09/09/2011 | WO2011041542A3 Herbal pain killer compositions |
| 09/09/2011 | WO2010059717A3 Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol |
| 09/09/2011 | CA2829180A1 A novel composition of matter for delivering lipid-soluble materials, and a method for producing it |
| 09/09/2011 | CA2792035A1 Compositions and methods for treating or preventing immuno-inflammatory disease |
| 09/09/2011 | CA2791661A1 Mucosal vaccines |
| 09/09/2011 | CA2791648A1 Antibody specific for apolipoprotein and methods of use thereof |
| 09/09/2011 | CA2791526A1 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
| 09/09/2011 | CA2791416A1 Derivatized hyperbranched polyglycerols |
| 09/09/2011 | CA2791386A1 Controlled delivery system |
| 09/09/2011 | CA2790652A1 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| 09/08/2011 | US20110218333 Internalizing ErbB2 antibodies |
| 09/08/2011 | US20110218252 Liquid Chromatographic Fraction of Enzymatically Polymerized Flavonoid as an Antioxidant |
| 09/08/2011 | US20110218251 Products with water clusters |
| 09/08/2011 | US20110218209 Nutrient delievry drug composition |
| 09/08/2011 | US20110218195 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 09/08/2011 | US20110218166 Mucoadherents compositions and their use |
| 09/08/2011 | US20110217366 Immunopotentiating composition |
| 09/08/2011 | US20110217354 Implants for administering substances and methods of producing implants |
| 09/08/2011 | US20110217353 Implants for administering substances and methods of producing implants |
| 09/08/2011 | US20110217343 Hydrolytically degradable alkylene oxide based polymers |